三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01530 三生制药

重阳节翌日休市 10-16 16:08:16

14.470

+0.110

+0.77%

最高14.910	最低14.300	成交量1,775万
今开14.680	昨收14.360	日振幅4.25%
总市值363.63亿	流通市值363.63亿	总股本25.13亿
成交额2.60亿	换手率0.71%	流通股本25.13亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"三生制药","latestPrice":14.47,"timestamp":1792138096002,"preClose":14.36,"halted":0,"volume":17751596,"delay":0,"changeRate":0.007660167130919305,"floatShares":2513000000,"shares":2513000000,"eps":3.43,"marketStatus":"重阳节翌日休市","change":0.11,"latestTime":"10-16 16:08:16","open":14.68,"high":14.91,"low":14.3,"amount":260166392,"amplitude":0.042479,"askPrice":14.47,"askSize":83500,"bidPrice":14.46,"bidSize":25000,"shortable":3,"etf":0,"ttmEps":3.750889,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792459800000},"marketStatusCode":7,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":14.36,"dividendRate":0.017367,"openAndCloseTimeList":[[1792114200000,1792123200000],[1792126800000,1792137600000]],"volumeRatio":0.8064965264367443,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"SBI.HK","impliedVol":0.487,"impliedVolPercentile":0.1212},"requestUrl":"/m/hq/s/01530","defaultTab":"news","newsList":[{"id":"1175856521","title":"三生制药10月14日回购33.75万股股份，涉资约486万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1175856521","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175856521?lang=zh_cn&edition=full","pubTime":"2026-10-14 17:45","pubTimestamp":1791971151,"startTime":"0","endTime":"0","summary":"三生制药于2026年10月14日发布公告，披露于香港联合交易所场内回购股份事宜。本次回购股份数为337,500股，约占此前公司已发行股本的0.01%。回购价格为每股14.40港元，合计涉资约486万港元。本次回购完成后，截至2026年10月14日，三生制药已发行股本数量变更为2,513,207,578股，库存股份数目相应增至25,113,500股，总已发行股份数维持在2,538,321,078股。据公告显示，三生制药此前于2026年6月25日获得股东大会通过的回购授权，回购股份的剩余额度仍可用于后续股份回购。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三生制药10月14日回购33.75万股股份，涉资约486万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675583353","title":"三生制药(01530)10月13日斥资1165万港元回购80万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675583353","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675583353?lang=zh_cn&edition=full","pubTime":"2026-10-13 18:18","pubTimestamp":1791886687,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药(01530)发布公告，于2026年10月13日，该公司斥资1165万港元回购80万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261013/32395438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["HK0000165453.HKD","BK1583","BK1593","01530","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118999646","title":"三生制药10月13日回购80.00万股股份，耗资约1,165.00万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118999646","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1118999646?lang=zh_cn&edition=full","pubTime":"2026-10-13 17:56","pubTimestamp":1791885393,"startTime":"0","endTime":"0","summary":"三生制药于2026年10月13日发布翌日报表公告，显示当日公司通过香港联交所场内回购股份80.00万股，占回购前公司已发行股本2,514,345,078股的0.03%。本次回购价格介乎每股14.50港元至14.60港元，合计耗资约1,165.00万港元。回购完成后，公司已发行股本降至2,513,545,078股，库藏股增至24,776,000股，公司已发行股份总数仍为2,538,321,078股。公告显示，三生制药于2026年6月25日获股东大会通过购回股份授权，总数为253,707,141股，其中已回购23,763,000股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三生制药10月13日回购80.00万股股份，耗资约1,165.00万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674592879","title":"三生制药(01530.HK)10月12日斥资1480万港元回购100万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674592879","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674592879?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:11","pubTimestamp":1791799891,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","01530","BK1583","BK1593","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100162386","title":"三生制药回购100万股股份，耗资约1,480万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1100162386","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100162386?lang=zh_cn&edition=full","pubTime":"2026-10-12 18:11","pubTimestamp":1791799879,"startTime":"0","endTime":"0","summary":"三生制药于2026年10月12日公告称，公司于香港联交所场内回购1,000,000股普通股，占该次回购前公司已发行股本约0.04%。此次回购价格介于每股14.70港元至14.90港元之间，总金额约14,800,000港元。公司表示，回购完成后，其已发行股本变动为2,514,345,078股，库藏股数量增至23,976,000股，股本总数为2,538,321,078股。根据公告，三生制药此前于2026年6月25日已通过回购授权，总额度为253,707,141股；迄今为止，公司已根据该授权累计回购22,963,000股，占授权通过当日已发行股本的约0.91%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三生制药回购100万股股份，耗资约1,480万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674856463","title":"汇添富基金管理股份有限公司减持三生制药(01530.HK)499.4万股 每股作价约15.82港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674856463","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674856463?lang=zh_cn&edition=full","pubTime":"2026-10-09 19:10","pubTimestamp":1791544217,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","HK0000165453.HKD","BK1593","BK1161","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674559278","title":"三生制药(01530)10月9日斥资3758.8万港元回购250万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2674559278","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674559278?lang=zh_cn&edition=full","pubTime":"2026-10-09 18:41","pubTimestamp":1791542518,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药(01530)发布公告，该公司于2026年10月9日斥资3758.8万港元回购250万股股份，每股回购价格为14.98-15.18港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505337.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01530","BK1593","BK1583","HK0000165453.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114709376","title":"三生制药10月9日回购250万股，耗资约3,758.80万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114709376","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114709376?lang=zh_cn&edition=full","pubTime":"2026-10-09 18:41","pubTimestamp":1791542516,"startTime":"0","endTime":"0","summary":"三生制药于2026年10月9日公告称，公司在香港联合交易所场内回购普通股250万股，占该次回购前公司已发行股本约0.1%。本次回购每股价格介乎14.98港元至15.18港元，合计耗资约3,758.80万港元。回购完成后，公司已发行股份总数减少至2,515,345,078股，库藏股数量相应增至22,976,000股。公告显示，本次股份回购基于公司于2026年6月25日通过的购回授权。相关授权允许公司最多回购253,707,141股，迄今公司已回购21,963,000股，占授权总数约0.87%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三生制药10月9日回购250万股，耗资约3,758.80万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156842934","title":"三生制药10月8日回购170.00万股，耗资约2,650.00万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1156842934","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1156842934?lang=zh_cn&edition=full","pubTime":"2026-10-08 18:26","pubTimestamp":1791455176,"startTime":"0","endTime":"0","summary":"三生制药于2026年10月8日发布公告，当日通过香港联交所场内回购普通股170.00万股，约占公司回购前已发行股本的0.07%。回购价格区间为每股15.40港元至15.75港元，合计耗资26,500,000港元。本次回购完成后，公司已发行股份总数减至2,517,845,078股，库藏股数增加至20,476,000股。截至公告日，公司可根据2026年6月25日通过的购回授权继续回购最多253,707,141股股份。公司明确表示，已遵守香港联合交易所有限公司证券上市规则及相关法例的规定。本次公告由公司秘书黎少娟签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三生制药10月8日回购170.00万股，耗资约2,650.00万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673229075","title":"三生制药(01530)10月8日斥资2650万港元回购170万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2673229075","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673229075?lang=zh_cn&edition=full","pubTime":"2026-10-08 18:19","pubTimestamp":1791454775,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药(01530)发布公告，于2026年10月8日该公司斥资2650万港元回购170万股，回购价格为每股15.4至15.75港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1504742.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1593","01530","BK1161","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673734038","title":"创新药概念普升 歌礼制药-B（01672）涨11.78%、再鼎医药（09688）涨6.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673734038","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673734038?lang=zh_cn&edition=full","pubTime":"2026-10-06 09:54","pubTimestamp":1791251688,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念普涨，截至发稿，歌礼制药-B 涨11.78%，再鼎医药涨6.55%，金斯瑞生物科技涨5.30%，晶泰控股涨4.40%，中国生物制药涨3.96%，三生制药涨3.41%，药明生物涨3.16%，康方生物涨3.11%，云顶新耀涨3.10%，四环医药涨2.82%。2026ESMO已公布LBA标题，29项LBA的试验药物由中国药企原研或参与开发，涉及约20家企业，其中5项进入主席研讨会。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1993103","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177","MEDX","LNGR","IE00BZ08YT58.USD","LU0029874061.USD","02228","LU0140636845.USD","LU0823426308.USD","BK1161","LU0029874905.USD","02269","LU0320764243.SGD","01952","LU0348784397.USD","LU0348735423.USD","LU0516422366.SGD","LU0320764599.SGD","BK1141","BK4588","IBBQ","06978","BK1515","HK0000306701.USD","KURE","LU0348766576.USD","ZLAB","01672","01548","BK1191","SG9999002463.SGD","LU0052750758.USD","159992","09926","IE00BPRC5H50.USD","LU0516423091.SGD","LU0348827113.USD","00460","BK4139","LU1242518931.SGD","BK1574","LU2778985437.USD","LU0708995153.HKD","BK1521","LU0211977185.USD","LU2476274308.USD","LU0417516902.SGD","01477","09688","LU0359201612.USD","01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157257950","title":"三生制药更新9月股份变动月报表，股本略增56,666股","url":"https://stock-news.laohu8.com/highlight/detail?id=1157257950","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157257950?lang=zh_cn&edition=full","pubTime":"2026-10-02 19:11","pubTimestamp":1790939488,"startTime":"0","endTime":"0","summary":"三生制药于2026年10月2日披露截至2026年9月30日的证券变动月报显示，公司法定股本未见变动，仍为500,000美元，对应50,000,000,000股普通股，每股面值为0.00001美元。截至9月末，普通股已发行股份为2,519,545,078股，库存股份为18,776,000股，合计2,538,321,078股。与上月底相比，已发行股份减少10,198,834股，库存股份增加10,255,500股，合计较8月底增长56,666股。同时，公司于2026年9月2日至9月29日期间，以每股15.162211-15.843853港元的价格回购股份共计10,255,500股，并将其列作库存股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193001984","title":"三生制药：花旗集团增持，好仓比例升至5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=1193001984","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193001984?lang=zh_cn&edition=full","pubTime":"2026-10-02 17:34","pubTimestamp":1790933689,"startTime":"0","endTime":"0","summary":"花旗集团于2026年9月25日因证券借贷池中持股比例增加而使其在三生制药（01530）的持股量增加约67.15万股，该笔变动无需支付代价，并非通过联交所公开市场直接买卖。花旗集团此次增持前持有三生制药好仓1.26亿股，占比4.99%；增持后持股量为1.27亿股，好仓比例升至5.02%。原文链接：Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189221916","title":"异动解读｜三生制药盘中下跌5.61%，报15.58港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1189221916","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189221916?lang=zh_cn&edition=full","pubTime":"2026-10-02 09:51","pubTimestamp":1790905864,"startTime":"0","endTime":"0","summary":"10月2日，三生制药盘中下跌5.61%，报15.58港元/股，成交额4822.29万港元。三生制药所在的生物科技行业整体承压，个股中，百济神州跌6.92%，信达生物跌5.05%，康方生物跌4.42%，科伦博泰生物跌5.75%，荣昌生物跌8.24%。三生制药是一家主要从事生物制药产品开发、生产、市场推广及销售的投资控股公司，主要产品包括特比澳、益比奥、益赛普等生物药物以及蔓迪、丽美治等小分子药物，同时开展CDMO业务。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671275129","title":"港股异动 | 三生制药(01530)涨超3% 旗下三生蔓迪携手德睿智药达成MDR-001独家合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2671275129","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671275129?lang=zh_cn&edition=full","pubTime":"2026-09-30 14:50","pubTimestamp":1790751052,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三生制药涨超3%，截至发稿，涨3.54%，报32.74港元，成交额1543.68万港元。消息面上，据三生制药官微消息，9月28日，三生制药旗下子公司浙江三生蔓迪药业有限公司及万晟医药宣布，与杭州德睿智药科技有限公司就其自主研发的AI设计口服小分子GLP-1受体激动剂MDR-001，达成覆盖中国内地、中国香港及中国澳门的独家商业化合作。MDR-001目前正在中国开展针对成人肥胖或超重人群的Ⅲ期关键临床研究。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01530","VXUS","BK1593","KCAI","BK1161","HK0000165453.HKD","BK4585","BK1583","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172136248","title":"三生制药：9月29日回购30万股，耗资约471万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172136248","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172136248?lang=zh_cn&edition=full","pubTime":"2026-09-29 18:01","pubTimestamp":1790676080,"startTime":"0","endTime":"0","summary":"三生制药(01530)于2026年9月29日回购普通股30万股，约占该事件前公司已发行股本（不包括库藏股）总数的0.01%。本次回购价格为每股15.7港元，总金额约471万港元。回购完成后，公司已发行股份增至2,519,488,412股，库藏股增至18,776,000股。根据公告，回购授权于2026年6月25日通过，公司可回购股票的总数为253,707,141股，迄今已在交易所及其他交易所累计回购17,763,000股，占授权通过当日已发行股本总数的0.7%。\n公司确认，本次交易严格遵守了香港联合交易所有限公司证券上市规则及相关法例的要求，且在回购中并无重大变动。公告由公司秘书黎少娟签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三生制药：9月29日回购30万股，耗资约471万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670235746","title":"三生制药(01530)9月28日斥资2041万港元回购130万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2670235746","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670235746?lang=zh_cn&edition=full","pubTime":"2026-09-28 18:03","pubTimestamp":1790589820,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三生制药(01530)发布公告，该公司于2026年9月28日斥资2041万港元回购130万股股份，每股回购价格为15.6-15.8港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501550.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HELS","BK1583","BK1593","01530","BK1161","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172568926","title":"三生制药：9月28日回购130万股股份，总额约2,041.00万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172568926","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1172568926?lang=zh_cn&edition=full","pubTime":"2026-09-28 18:02","pubTimestamp":1790589739,"startTime":"0","endTime":"0","summary":"三生制药于2026年9月28日发布翌日披露报表，公告当日通过香港联合交易所场内回购1,300,000股普通股股份，约占该公司已发行股本0.05%。每股回购价格介乎15.60港元至15.80港元，合计涉资20,410,000港元。回购完成后，公司已发行股份总数由2,521,088,412股变动为2,519,788,412股，库藏股数增至18,476,000股。三生制药方面确认，此次回购严格遵守香港联合交易所证券上市规则及相关法律法规，符合所有适用规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"三生制药：9月28日回购130万股股份，总额约2,041.00万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192995461","title":"异动解读｜三生制药盘中下跌5.06%，报16.15港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192995461","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192995461?lang=zh_cn&edition=full","pubTime":"2026-09-24 14:03","pubTimestamp":1790229829,"startTime":"0","endTime":"0","summary":"9月24日，三生制药盘中下跌5.06%，报16.15港元/股，成交额1.49亿港元。三生制药所在的生物科技行业整体承压，个股中，信达生物跌3.72%，康方生物跌4.26%，诺诚健华跌11.17%，百济神州跌1.92%，荣昌生物跌8.25%。三生制药是一家主要从事生物制药产品的开发、生产、市场推广及销售的投资控股公司，主要产品包括特比澳、益比奥、益赛普等生物药物，同时开展CDMO业务，产品主要应用于血小板减少症、慢性肾病引起的贫血症等领域。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669548376","title":"三生“少帅”娄竞：从科学家到操盘手，是药二代更是创一代","url":"https://stock-news.laohu8.com/highlight/detail?id=2669548376","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669548376?lang=zh_cn&edition=full","pubTime":"2026-09-23 20:02","pubTimestamp":1790164971,"startTime":"0","endTime":"0","summary":"三生官方资料将其列为益比奥、特比澳开发的领导科学家和主要研究员。2007年三生制药登陆纳斯达克，是国内较早赴美上市的生物药企之一。2015年三生回港上市，公司大事记称其当年成为全球生物制药领域受关注IPO之一。娄竞接手后先扩后收，早期保留赛普汀等肿瘤抗体，2020年前后逐步把资源收回到自身免疫。国健年报披露，相关款项三生国健占30%、沈阳三生占70%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1790134731525398876","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK0239","BK1593","688336","01530","BK1583","HK0000165453.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":-0.0398},{"period":"1month","weight":-0.0772},{"period":"3month","weight":-0.0908},{"period":"6month","weight":-0.4187},{"period":"1year","weight":-0.4965},{"period":"ytd","weight":-0.3927}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":-0.0213},{"period":"3month","weight":-0.0153},{"period":"6month","weight":-0.0754},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":-0.0563}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"3SBio Inc是一家主要从事生物制药产品的开发、生产、市场推广及销售的投资控股公司。该公司的主要产品包括特比澳、益比奥、益赛普、赛普汀等生物药物以及蔓迪、丽美治等小分子药物。该公司还从事为客户提供多种生物药的研发生产以及治疗技术平台服务的合同开发与生产运营（CDMO）业务。该公司的产品主要应用于血小板减少症（CIT）、慢性肾病（CKD）引起的贫血症、治疗化疗引起的贫血症（CIA）、强直性嵴柱炎（AS）及银屑病等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":-0.006634},{"month":2,"riseRate":0.454545,"avgChangeRate":0.001777},{"month":3,"riseRate":0.818182,"avgChangeRate":0.113184},{"month":4,"riseRate":0.454545,"avgChangeRate":-0.011081},{"month":5,"riseRate":0.636364,"avgChangeRate":0.080953},{"month":6,"riseRate":0.727273,"avgChangeRate":0.025359},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.034677},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.015863},{"month":9,"riseRate":0.666667,"avgChangeRate":0.027514},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.027353},{"month":11,"riseRate":0.727273,"avgChangeRate":0.059928},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.045348}],"exchange":"SEHK","name":"三生制药","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生制药,01530,三生制药股票,三生制药股票老虎,三生制药股票老虎国际,三生制药行情,三生制药股票行情,三生制药股价,三生制药股市,三生制药股票价格,三生制药股票交易,三生制药股票购买,三生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}